# 111

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/111

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.111.com.cn
- Total disclosed funding: $261M
- Latest round: Series D (Oct 16, 2015)
- Investors on record: 8

## About

Founded in 2010 and based in Shanghai, China, 111, Inc. operates an online marketplace for medical and pharmaceutical products. Yu Gang, the company's co-founder and executive chairman, Former VP of Global Procurement at Dell and VP of Global Supply Chain at Amazon. The company's co-founder, Chairman and CEO, Mr. Junling Liu, was previously Global Vice President of Dell, President of Dell China and Hong Kong, and President of Avaya China.

The company's main business is the sales of Chinese and Western medicines, pharmaceutical and personal care products, adult products and healthcare products. In addition, it provides users with services such as easy medical consultation, health encyclopedia, thematic shopping guide for drugs, nutritional matching suggestions, etc. It also provides users with services such as online payment and cash-on-delivery through a combination of online and offline marketing model.

## Funding rounds

- Series D, Oct 16, 2015, $188M — Verlinvest, Dangdai Group, Zhuoer Capital, Allied China Investment Limited, Tongyi Investment Holdings Limited
- Series C, Dec 31, 2014, $73M — Verlinvest, ClearVue Partners, First Pharmacia International, Rich Chance Global Limited

## Investors

- Verlinvest — Series C, Series D
- ClearVue Partners (https://capitalatlas.ai/funds/clearvue-partners) — Series C
- First Pharmacia International — Series C
- Rich Chance Global Limited — Series C
- Dangdai Group — Series D
- Zhuoer Capital — Series D
- Allied China Investment Limited — Series D
- Tongyi Investment Holdings Limited — Series D